Related Experiment Video
Updated: Jun 6, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine: Innovation in Treatment, Policy Support, and Patient Perspectives.
Mubashir S Angolkar1, Ashwini B Narasannavar2, Rajan Rajesh3
1Professor and Head, Department of Public Health, JNMC, KAHER, Belagavi, Karnataka, India.
Indian Journal of Public Health
|June 4, 2026
Summary
Migraine affects over 213 million Indians, predominantly women, posing a significant public health challenge. Addressing clinical, social, and policy gaps is crucial for effective migraine management and reducing disease burden.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Migraine is a chronic neurological disorder and a leading cause of disability globally.
- India faces a significant public health challenge with migraine prevalence estimated between 14% and 28.7%.
Purpose of the Study:
- To assess the epidemiological burden of migraine in India.
- To examine clinical, social, and infrastructural challenges impacting migraine management and policy support.
Main Methods:
- A narrative review of peer-reviewed literature from 2015-2025 using PubMed, Scopus, and Web of Science.
- Inclusion of expert insights via thematic analysis of discussions from the 69th Annual National Conference of the Indian Public Health Association.
Main Results:
- Migraine impacts over 213 million individuals in India, disproportionately affecting women and working-age populations.
- Limited access to personalized and innovative treatments due to regulatory and insurance gaps.
- Policy neglect and sociocultural stigma worsen the disease burden and economic loss.
Conclusions:
- Migraine's debilitating nature and economic impact in India are under-recognized in policy and insurance frameworks.
- A multidisciplinary, patient-centered approach is essential, integrating clinical innovation, policy reform, and mental health support.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...